Banque Cantonale Vaudoise Amgen Inc Transaction History

Banque Cantonale Vaudoise

$2.43 Billion
Q3 2024

A detailed history of Banque Cantonale Vaudoise transactions in Amgen Inc stock. As of the latest transaction made, Banque Cantonale Vaudoise holds 21,142 shares of AMGN stock, worth $5.57 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

21,142

Previous 32,716 35.38%

Holding current value

$5.57 Million

Previous $10.2 Million 33.36%

% of portfolio

0.28%

Previous 0.41%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$309.38 - $337.38 $3.58 Million - $3.9 Million	-11,574 Reduced 35.38%	21,142 $6.81 Million
Q2 2024 Jul 31, 2024	BUY	$262.75 - $319.31 $180,772 - $219,685	688 Added 2.15%	32,716 $10.2 Million
Q1 2024 Apr 10, 2024	BUY	$268.87 - $324.56 $237,949 - $287,235	885 Added 2.84%	32,028 $9.11 Million
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $1.68 Million - $1.89 Million	6,566 Added 26.72%	31,143 $8.97 Million
Q3 2023 Nov 08, 2023	SELL	$218.65 - $271.46 $318,354 - $395,245	-1,456 Reduced 5.59%	24,577 $6.61 Million
Q2 2023 Aug 09, 2023	SELL	$214.27 - $253.37 $1.01 Million - $1.2 Million	-4,726 Reduced 15.36%	26,033 $5.78 Million
Q1 2023 Apr 20, 2023	BUY	$225.79 - $275.2 $1.7 Million - $2.08 Million	7,546 Added 32.51%	30,759 $7.44 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $1.35 Million - $1.72 Million	-5,902 Reduced 20.27%	23,213 $6.1 Million
Q3 2022 Oct 17, 2022	BUY	$224.46 - $253.15 $180,914 - $204,038	806 Added 2.85%	29,115 $6.56 Million
Q2 2022 Aug 02, 2022	BUY	$230.71 - $256.74 $687,515 - $765,085	2,980 Added 11.77%	28,309 $6.89 Million
Q1 2022 May 09, 2022	SELL	$219.27 - $242.57 $970,708 - $1.07 Million	-4,427 Reduced 14.88%	25,329 $6.13 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $1.08 Million - $1.24 Million	5,434 Added 22.34%	29,756 $6.69 Million
Q3 2021 Oct 29, 2021	SELL	$212.27 - $248.7 $2.52 Million - $2.95 Million	-11,870 Reduced 32.8%	24,322 $5.17 Million
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $433,057 - $480,445	-1,854 Reduced 4.87%	36,192 $8.82 Million
Q1 2021 May 11, 2021	SELL	$221.91 - $258.6 $579,628 - $675,463	-2,612 Reduced 6.42%	38,046 $9.47 Million
Q4 2020 Feb 05, 2021	SELL	$216.38 - $257.67 $251,000 - $298,897	-1,160 Reduced 2.77%	40,658 $9.35 Million
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $1.51 Million - $1.68 Million	6,426 Added 18.16%	41,818 $10.6 Million
Q2 2020 Jul 22, 2020	BUY	$197.81 - $242.74 $635,959 - $780,409	3,215 Added 9.99%	35,392 $8.35 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $269,897 - $357,957	-1,481 Reduced 4.4%	32,177 $6.52 Million
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $6.37 Million - $8.19 Million	33,658 New	33,658 $8.11 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

News

Stay updated on Banque Cantonale Vaudoise with notifications on news.

Account

Banque Cantonale Vaudoise Amgen Inc Transaction History